Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Adverum Biotechnologies
Adverum Biotechnologies
July Brings Layoffs, Job Creation for the Life Sciences
BioSpace
Wed, 08/3/22 - 09:32 pm
layoffs
hirings
Astellas
Pfizer
Eikon Therapeutics
Bayer
Avadel Pharma
Heron Therapeutics
Adverum Biotechnologies
Biogen
Eisai
X4 Pharmaceuticals
Assembly Biosciences
Half of Adverum pipeline 'snaps out of existence' as adverse events force pivot to more common eye disease
Fierce Biotech
Fri, 07/23/21 - 11:07 am
Adverum Biotechnologies
ADVM-022
diabetic macular edema
gene therapy
Adverum gene therapy trial sees disruption after serious side effect reported
Biopharma Reporter
Thu, 04/29/21 - 10:39 am
Adverum Biotechnologies
diabetic macular edema
gene therapy
clinical trials
The Week Ahead In Biotech: Merck, Bristol-Myers Earnings, Conference Presentations In Focus
Yahoo/Benzinga
Mon, 02/3/20 - 10:37 am
earnings
Forty Seven
Jounce Therapeutics
Catalyst Biosciences
Kodiak Sciences
Adverum Biotechnologies
IPOs
Beam Therapeutics
3 Soaring Biotech Stocks to Watch in December
Motley Fool
Mon, 12/2/19 - 10:40 am
Arrowhead Pharmaceuticals
RNAi
Adverum Biotechnologies
gene therapy
ADVM-022
Arqule
ARQ-531
Early snapshot of Adverum's eye gene therapy sparks concern about vision loss
Endpoints
Sat, 09/14/19 - 11:25 am
Adverum Biotechnologies
wet age-related macular degeneration
gene therapy
ADVM-022
Adverum Up as FDA Lifts Hold on Cohort of Wet AMD Study
Yahoo/Zacks.com
Tue, 05/21/19 - 09:35 am
Adverum Biotechnologies
FDA
clinical trials
ADVM-022
wet age-related macular degeneration
3 Biotech Stocks That Soared Last Week
Motley Fool
Sun, 05/19/19 - 04:02 pm
Adverum Biotechnologies
ADVM-022
Iovance
LN-145
cervical cancer
MeiraGTx
AAV-RPE65
Bio Roundup: Nationwide’s Rise, a Surgeon’s Quest, CRISPR USA & More
Xconomy
Sun, 04/21/19 - 12:16 am
FDA
CRISPR
gene therapy
Achaogen
Allergan
Alnylam
Adverum Biotechnologies
Blackstone Life Sciences
Adverum Bio offers a late notification about FDA hold on lead gene therapy for wet AMD
Endpoints
Mon, 04/15/19 - 11:12 pm
Adverum Biotechnologies
CMC
gene therapy
wet age-related macular degeneration
FDA
Adverum Biotechnologies Receives Orphan Drug Designation for Hereditary Angioedema Gene Therapy Candidate
CP Wire
Fri, 08/24/18 - 11:00 am
Adverum Biotechnologies
ADVM-053
hereditary angiodema
HAE
FDA
Adverum Biotechnologies Receives Orphan Drug Designation for Hereditary Angioedema Gene Therapy Candidate
Fri, 08/24/18 - 09:50 am
Adverum Biotechnologies
ADVM-053
hereditary angiodema
Adverum Biotechnologies Announces Positive Results in Preclinical Study of ADVM-022 Gene Therapy in Wet AMD
CP Wire
Tue, 05/1/18 - 11:15 am
Adverum Biotechnologies
ADVM-022
wet age-related macular degeneration
Adverum Biotechnologies Announces Positive Results in Preclinical Study of ADVM-022 Gene Therapy in Wet AMD
Tue, 05/1/18 - 09:42 am
Adverum Biotechnologies
macular degeneration
wet age-related macular degeneration